Founded in 2020, the CarDS Lab has been at the forefront of creating AI-based applications to improve medical diagnoses of ...
STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN ...
MedPage Today on MSN1d
Trump Team Fires Alzheimer's Staff; Herpesvirus and Alzheimer's; MS Drug SwitchesAmong those fired in the recent spate of Trump administration cuts are staff members at the NIH's Center for Alzheimer's and ...
STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) ), a pharmaceutical company that develops candidate drugs for ...
StudyFinds on MSN2d
These drugs could give Alzheimer’s patients a longer life of independence, study showsExplore the latest advancements in Alzheimer's treatment and the impact of new medications on patient independence and daily ...
Zentara, a groundbreaking new company, is pushing to steer the conversation away from these ineffective tactics to ...
LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) began 2025 with a pair of potentially ...
There are two significant, nonscientific obstacles – a shortage of funding and patent law – that will require concerted effort by scientists, concerned citizens, society and our lawmakers to overcome.
Short sleepers cruise by on four to six hours a night and don’t seem to suffer ill effects. Turns out they’re genetically ...
Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...
New research suggests that consistent aerobic exercise could be a powerful tool in reducing the biological signs associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback